跳至主要内容
临床试验/TCTR20210221003
TCTR20210221003招募中4 期

Oxymetazoline adds to the efficacy of Fluticasone furoate in the treatment of persistent rhinitis

the Faculty of Medicine, Prince of Songkla University0 个研究点目标入组 160 人开始时间: 2021年2月21日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Patients aged between 15 and 65 years
  • 2. Had rhinitis symptoms: two or more symptoms of nasal obstruction, rhinorrhea, and
  • sneezing and/or nasal itching
  • 3. persistent symptom for at least 3 months

排除标准

  • 1. Had used intranasal or inhaled or systemic steroids within 1 month
  • 2. Had used systemic steroids within 2 months
  • 3. Had used decongestion or antihistamines within 7 days
  • 4. Had undergone sinonasal surgery or immunotherapy
  • 5. Symptoms or physical signs suggestive of renal, hepatic, or
  • cardiovascular disease, concomitant sinusitis, nasal polyposis,
  • and septal deviation.
  • 6. Recent URI within past 4 weeks
  • 7 Contraindication to allergy skin test
  • 8. Current smokers
  • 9. Contraindication to corticosteroids and decongestants

研究者

发起方
the Faculty of Medicine, Prince of Songkla University

相似试验